ViraCyte LLC
Biotech · Acquired
Off-the-shelf banked virus-specific T cells (Viralym-B) for BK virus infection in immunocompromised patients
- Grants
- $6.0M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Path to Commercialization of the first “off the shelf” T cell product | $988,677 | |
| Federal grant | Department of Health and Human Services · Phase II · Path to Commercialization ofthe first "off the shelf" T cell product | $2,998,013 | |
| Federal grant | Department of Health and Human Services · Phase II · Path to Commercialization of the first “off the shelf” T cell product | $986,769 | |
| Federal grant | Department of Health and Human Services · Phase II · Path to Commercialization of the first “off the shelf” T cell product | $1,022,567 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2049 | Seven Bridges Capital LLC | — | $1.0M |
| 2050 | SAMDI TECH, INC. | — | — |
| 2051 | CORD BLOOD PLUS, INC. | — | — |
| 2052 | ViraCyte LLC | — | — |
| 2053 | Tome Biosciences | — | — |
| 2054 | Advanced Solutions Holdings, Inc. | — | $36M |
| 2055 | CATENA BIOSCIENCES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.